This track will explore the latest breakthroughs in cancer genomics, focusing on the identification of genetic mutations associated with various cancer types. Discussions will include the implications of these findings for personalized medicine and targeted therapies.

This session will delve into the molecular mechanisms underlying cancer development and progression, highlighting innovative approaches in molecular oncology. Participants will examine novel therapeutic targets and their potential applications in clinical settings.

This track will focus on the role of tumor genetics in the identification of cancer biomarkers, which are crucial for early diagnosis and treatment. The session will cover recent discoveries and their implications for precision medicine.

This session will discuss the development and application of targeted therapies in oncology, emphasizing their effectiveness in treating specific cancer types. Experts will share insights on the challenges and successes of implementing these therapies in clinical practice.

This track will provide an overview of oncogenomics, focusing on the genetic alterations that drive cancer. Participants will explore how these insights can inform the development of personalized treatment strategies.

This session will address the detection of cancer mutations and their implications for patient management and treatment decisions. The discussion will include advanced genomic sequencing technologies and their role in enhancing cancer diagnostics.